• Biospecimen SolutionsPrecision Value & HealthCareers
    P_ForMedicine_no_tag_RGBP_ForMedicine_no_tag_RGBP_ForMedicine_no_tag_RGBP_ForMedicine_no_tag_RGB
    • Clinical
      Trial Services
        • Overview
            • Oncology Clinical TrialsImage

              Oncology Clinical Trials


              Through 20+ years running successful oncology trials, we’ve developed a unique blend of proprietary technologies, flexible processes, and creative problem solving abilities that advance even the most challenging clinical development programs.

              • Rare & Orphan DiseaseImage

                Rare & Orphan Disease


                With experience built on 150+ orphan disease projects covering 80+ rare diseases, we know how to anticipate logistical and regulatory obstacles and craft bold solutions that drive rare disease development programs.

        • Global Clinical Trial Support
            • North & South America
              • Oncology Clinical TrialsImage

                Oncology Clinical Trials


                Through 20+ years running successful oncology trials, we’ve developed a unique blend of proprietary technologies, flexible processes, and creative problem solving abilities that advance even the most challenging clinical development programs.

            • Europe
              • Oncology Clinical TrialsImage

                Oncology Clinical Trials


                Through 20+ years running successful oncology trials, we’ve developed a unique blend of proprietary technologies, flexible processes, and creative problem solving abilities that advance even the most challenging clinical development programs.

            • APAC
              • Oncology Clinical TrialsImage

                Oncology Clinical Trials


                Through 20+ years running successful oncology trials, we’ve developed a unique blend of proprietary technologies, flexible processes, and creative problem solving abilities that advance even the most challenging clinical development programs.

        • Clinical Trial Management
            • Study Start-up & Feasibility
              • Oncology Clinical TrialsImage

                Oncology Clinical Trials


                Through 20+ years running successful oncology trials, we’ve developed a unique blend of proprietary technologies, flexible processes, and creative problem solving abilities that advance even the most challenging clinical development programs.

            • Project Management
            • Patient Recruitment
            • Personalized Clinical Trial Operations
            • Biometrics
            • Medical & Safety Monitoring
            • Clinical Data Management
            • Medical Writing
        • Clinical Development Strategy
            • Clinical Development Planning
              • Oncology Clinical TrialsImage

                Oncology Clinical Trials


                Through 20+ years running successful oncology trials, we’ve developed a unique blend of proprietary technologies, flexible processes, and creative problem solving abilities that advance even the most challenging clinical development programs.

            • Biomarker Strategies
            • Cell & Gene Therapy Strategies
            • CDx Regulatory and Market Access
        • Clinical Trial Design
            • Basket & Umbrella Trials
              • Oncology Clinical TrialsImage

                Oncology Clinical Trials


                Through 20+ years running successful oncology trials, we’ve developed a unique blend of proprietary technologies, flexible processes, and creative problem solving abilities that advance even the most challenging clinical development programs.

            • Biomarker Clinical Trials
            • Master Protocol Trials
            • Decentralized Clinical Trials
        • Biostatistics
            • Statistical Consulting
              • Oncology Clinical TrialsImage

                Oncology Clinical Trials


                Through 20+ years running successful oncology trials, we’ve developed a unique blend of proprietary technologies, flexible processes, and creative problem solving abilities that advance even the most challenging clinical development programs.

            • Study Design
            • Data Monitoring Committees
            • CDISC Programming and Documentation
            • eCTD Submissions
        • Central Lab Services
            • Clinical Specimen Kitting
              • Oncology Clinical TrialsImage

                Oncology Clinical Trials


                Through 20+ years running successful oncology trials, we’ve developed a unique blend of proprietary technologies, flexible processes, and creative problem solving abilities that advance even the most challenging clinical development programs.

            • Sample Processing
            • Global Specimen Logistics and Biostorage
            • Biospecimen Data Services
            • Precision Lab e-Portal
            • Virtual Sample Inventory Management
        • Training
            • Oncology Clinical TrialsImage

              Oncology Clinical Trials


              Through 20+ years running successful oncology trials, we’ve developed a unique blend of proprietary technologies, flexible processes, and creative problem solving abilities that advance even the most challenging clinical development programs.

              • Rare & Orphan DiseaseImage

                Rare & Orphan Disease


                With experience built on 150+ orphan disease projects covering 80+ rare diseases, we know how to anticipate logistical and regulatory obstacles and craft bold solutions that drive rare disease development programs.

    • Lab
      Services
        • Central Lab Services
            • Clinical Specimen Kitting
              • Oncology Clinical TrialsImage

                Oncology Clinical Trials


                Through 20+ years running successful oncology trials, we’ve developed a unique blend of proprietary technologies, flexible processes, and creative problem solving abilities that advance even the most challenging clinical development programs.

            • Sample Processing
            • Global Specimen Logistics and Biostorage
            • Biospecimen Data Services
            • Precision Lab e-Portal
            • Virtual Sample Inventory Management
        • Specialty Lab Services Overview
            • Immune MonitoringImage

              Immune Monitoring


              Leverage sophisticated immune monitoring approaches, including flow cytometry, Epiontis ID immune cell phenotyping, and cytokine profiling, to characterize the immune cells in your samples and understand their impact on patient biology.

              • Tissue & Liquid BiopsyImage

                Tissue and Liquid Biopsy


                Obtain a detailed molecular view into patient biology with a range of tissue and liquid biopsy technologies, including our proprietary ApoStream platform which can isolate and enrich circulating tumor cells for downstream analysis.

        • EU Contract Research Organization
        • Immune Monitoring
            • Immune Monitoring by Flow Cytometry
              • Immune MonitoringImage

                Immune Monitoring


                Leverage sophisticated immune monitoring approaches, including flow cytometry, Epiontis ID immune cell phenotyping, and cytokine profiling, to characterize the immune cells in your samples and understand their impact on patient biology.

            • Immune Cell Phenotyping by Epiontis ID
            • Cytokine Profiling
            • Gene Expression Profiling
            • ELISpot and FluoroSpot
            • Custom Assays
        • Flow Cytometry
            • Receptor Occupancy Assays by Flow Cytometry
              • Immune MonitoringImage

                Immune Monitoring


                Leverage sophisticated immune monitoring approaches, including flow cytometry, Epiontis ID immune cell phenotyping, and cytokine profiling, to characterize the immune cells in your samples and understand their impact on patient biology.

        • Genomics
            • NanoString Assays
              • Immune MonitoringImage

                Immune Monitoring


                Leverage sophisticated immune monitoring approaches, including flow cytometry, Epiontis ID immune cell phenotyping, and cytokine profiling, to characterize the immune cells in your samples and understand their impact on patient biology.

            • ddPCR
            • qPCR
            • NGS
            • Fluorescence In Situ Hybridisation (FISH) / ISH
        • Tissue & Liquid Biopsy
            • ApoStream – CTC and Rare Cell Isolation for Liquid Biopsy
              • Immune MonitoringImage

                Immune Monitoring


                Leverage sophisticated immune monitoring approaches, including flow cytometry, Epiontis ID immune cell phenotyping, and cytokine profiling, to characterize the immune cells in your samples and understand their impact on patient biology.

            • CTC / cfDNA / Exosome Analysis
            • Multiplex Immunofluorescence
            • Immunohistochemistry
            • Fluorescence In Situ Hybridisation (FISH) / ISH
            • Pathology Services
            • NanoString Assays
        • Bioanalytical Testing
            • Immunogenicity Testing
              • Immune MonitoringImage

                Immune Monitoring


                Leverage sophisticated immune monitoring approaches, including flow cytometry, Epiontis ID immune cell phenotyping, and cytokine profiling, to characterize the immune cells in your samples and understand their impact on patient biology.

            • PK Assays
            • ADA Assays
            • MesoScale Discovery (MSD) Assays
            • Quanterix SIMOA
            • ELISA
        • Protein & Cytokine Analysis
            • ELISA
              • Immune MonitoringImage

                Immune Monitoring


                Leverage sophisticated immune monitoring approaches, including flow cytometry, Epiontis ID immune cell phenotyping, and cytokine profiling, to characterize the immune cells in your samples and understand their impact on patient biology.

            • MesoScale Discovery (MSD) Assays
            • Luminex
            • Quanterix SIMOA
            • Automated Western Blotting
        • Preclinical Target and Biomarker Validation
            • Cell Based Assays
            • Target Expression – XpressWay Profiles
            • Tissue Cross-Reactivity
            • Fluorescence In Situ Hybridisation (FISH) / ISH
            • Multiplex Immunofluorescence
            • Immunohistochemistry (IHC)
        • Biospecimens
            • Immune MonitoringImage

              Immune Monitoring


              Leverage sophisticated immune monitoring approaches, including flow cytometry, Epiontis ID immune cell phenotyping, and cytokine profiling, to characterize the immune cells in your samples and understand their impact on patient biology.

              • Tissue & Liquid BiopsyImage

                Tissue and Liquid Biopsy


                Obtain a detailed molecular view into patient biology with a range of tissue and liquid biopsy technologies, including our proprietary ApoStream platform which can isolate and enrich circulating tumor cells for downstream analysis.

    • Data
      Sciences
        • Overview
            • BiostatisticsImage

              Biostatistics


              Seasoned biostatisticians and statistical programmers support every phase of your trial, from study design for small, rare disease trials to regulatory submissions, all backed by meticulous documentation.

              • QuartzBioImage

                QuartzBio® Solutions


                Purpose-built SaaS solutions developed to address the complex, manual, and siloed processes that exist in sample and biomarker data management by delivering innovative data-enabling technologies in a single, scalable platform.

        • Biostatistics
        • Clinical Data Management
        • Biometrics
        • QuartzBio® Solutions
            • enterprise Biomarker Data Management (eBDM)
              • BiostatisticsImage

                Biostatistics


                Seasoned biostatisticians and statistical programmers support every phase of your trial, from study design for small, rare disease trials to regulatory submissions, all backed by meticulous documentation.

            • virtual Sample Inventory Management (vSIM)
            • Analytics, Information, Insights, and Reporting
    • Diagnostics
      & CDx
        • IVD and CDx Regulatory Affairs Consulting
          • spevialty_labs_slice-300×54Image

            Specialty Lab Services


            Our comprehensive approach starts with a foundation of expertise in key biomaker discovery and analysis methods such as immune monitoring, genomics, and bioanalysis.

        • COVID-19 & Viral Panel Assays
          • spevialty_labs_slice-300×54Image

            Specialty Lab Services


            Our comprehensive approach starts with a foundation of expertise in key biomaker discovery and analysis methods such as immune monitoring, genomics, and bioanalysis.

        • Biospecimens Solutions 
          • spevialty_labs_slice-300×54Image

            Specialty Lab Services


            Our comprehensive approach starts with a foundation of expertise in key biomaker discovery and analysis methods such as immune monitoring, genomics, and bioanalysis.

        • Diagnostic Market Access Services
          • spevialty_labs_slice-300×54Image

            Specialty Lab Services


            Our comprehensive approach starts with a foundation of expertise in key biomaker discovery and analysis methods such as immune monitoring, genomics, and bioanalysis.

        • Companion Diagnostics
    • Therapeutic
      Areas
        • Overview
            • By Specialty Area
              • Global-clinical-trial-support-2Image

                Global Clinical Trial Support


                Sample processing labs, clinical trial sites and offices in five continents provide the clinical reach and scale to manage complex global programs.

            • Oncology and Immuno-Oncology
              • Oncology Clinical Trials
            • Rare & Orphan Disease
              • Global-clinical-trial-support-2Image

                Global Clinical Trial Support


                Sample processing labs, clinical trial sites and offices in five continents provide the clinical reach and scale to manage complex global programs.

            • Cell & Gene Therapy
              • Cell Therapy
              • Gene Therapy
              • Cell and Gene Therapy Manufacturing
            • CNS & Neuroscience
              • Global-clinical-trial-support-2Image

                Global Clinical Trial Support


                Sample processing labs, clinical trial sites and offices in five continents provide the clinical reach and scale to manage complex global programs.

            • COVID-19
            • AutoImmune & Allergy
            • Pediatric
        • By Research Phase
        • Preclinical Development
        • Early Phase Trials (I-IIa)
        • Late Phase Trials (IIb-III)
    • News &
      Insights
        • Blog
            • iStock-945738094Image

              Blog


              Industry trends and best practices from Precision experts

              • shutterstock_1033743346Image

                Resources


                A searchable hub featuring the latest Precision case studies, white papers, capabilities brochures and more.

        • Resources
        • Thought Leadership
        • News
            • iStock-945738094Image

              Blog


              Industry trends and best practices from Precision experts

              • shutterstock_1033743346Image

                Resources


                A searchable hub featuring the latest Precision case studies, white papers, capabilities brochures and more.

        • Events
            • iStock-945738094Image

              Blog


              Industry trends and best practices from Precision experts

              • shutterstock_1033743346Image

                Resources


                A searchable hub featuring the latest Precision case studies, white papers, capabilities brochures and more.

    • About
      Us
        • Our Passion
            • Patient RecruitmentImage

              Our Passion


              What we do, why we do it and the principles that guide us every day.

              • meet-our-peopleImage

                Meet Our People


                We are devoted professionals with deep expertise in translational science, clinical trials and data sciences.

        • Meet Our People
        • Careers
        • Regulatory Information
            • Patient RecruitmentImage

              Our Passion


              What we do, why we do it and the principles that guide us every day.

              • meet-our-peopleImage

                Meet Our People


                We are devoted professionals with deep expertise in translational science, clinical trials and data sciences.

    • Contact
      Us
    ✕
    • Home
    • Best Practices for Database Transfer in a Rescue Study
    Blog Clinical Research Insights Translational & Lab Insights
    Article

    Best Practices for Database Transfer in a Rescue Study

    Written By Nancy Bates
    September 23, 2022 • 7 min. read

    Easing the transition, protecting your outcomes

    On occasion, a Sponsor may need to employ a rescue CRO for some or all of an ongoing study. Whether it is due to slow enrollment or a more systemic problem, the decision to change CROs is never made lightly, and a critical component of any successful transition is effective, efficient transfer of the study database.  

    In this article, we cover the key elements of a successful database transition. To learn more about handing off Data Management activities, read our article on Transitioning a Rescue Study: Data Management Considerations. 

    Communication is Key

    Vital to the success of any study transition is clear communication between the Sponsor and the Lead Data Manager of the incoming CRO. Establishing preferences and expectations for communication—frequency, format, and content—helps solidify the engagement and keep the transition on track. 

    Planning and Preparing for Database Transition

    Developing a transition plan, timeline, and transition checklist is crucial for ensuring that the database transition is as seamless as possible. Typically, the incoming CRO develops a draft transition plan and timeline after the scope of work and budget have been defined. The CRO also requests and reviews key documents, including all versions of the protocol and copies of the data management plan, data review plan, case report forms (CRFs), annotated CRFs (aCRFs), configuration settings, edit check specifications, CRF completion guidelines, coding licensure information, local laboratory reference ranges, if applicable, and external vendor contact information.  

    This is followed by a kickoff meeting with the Sponsor, where there is a deeper discussion of how the Sponsor wishes to handle the existing study database and whether there are any upcoming interim analyses or safety review meetings that require a data cut. The kickoff meeting is also an optimal time to establish a data entry cutoff data for the sites and for monitoring visits. Following the kickoff meeting, the incoming CRO should have all the information necessary to finalize the transition plan and timeline and to create the transition checklist that will guide the Data Management and Database Programming teams through all the steps required for the transition. 

    The success of a study transition depends on clear communication between the Sponsor and the Lead Data Manager of the incoming CRO

    Determining How to Transfer the Database

    A key variable impacting the timeline is what the Sponsor wants to do with the database. There are several options for the data and database, depending on the type of data, who retains administrative rights for updates, and the URL upon which the electronic data capture (EDC) system resides. These database options include: 

    Directly transferring the database URL to the incoming CRO

    In this scenario, the incoming CRO assumes responsibility for all management and administrative duties for all related modules, maintenance, revisions or updates, and database locking.

    Direct transfer of the database URL or the study database and all environments and modules, along with administrative access, is the most common and preferred option among the Sponsors we have worked with at Precision for Medicine. Administrative access is necessary for allowing future database updates and requires coordination with the outgoing CRO and the database vendor.

    Importantly, while the URL, environments, modules, and administrative access are transferred to the incoming CRO, the original database configuration settings cannot be changed as they are owned by the outgoing CRO or database vendor and any change would affect all the outgoing CRO’s studies that were on the same URL. Configuration settings affect multiple functions, such as roles, permissions, lab administration, and clinical views. Consequently, the Sponsor and the Data Management and Database Programming teams need to be aware of any differences in configuration settings so they can be addressed during the database transfer.

    Leaving the database with the vendor that built it

    That vendor retains administrative rights and assumes responsibility for making database changes and performing database final lock activities. The incoming CRO’s data management activities are limited to data cleaning and query management. 

    Building a new database

    The incoming CRO builds a new database and data from the existing database is either re-entered manually by the sites (or another designated group) or programmatically remapped and uploaded by the incoming CRO. Manual re-entry may be preferred, as remapping and uploading requires extensive preparation and quality control (QC) and is invariably more costly and time-consuming.

    If the Sponsor prefers to build a new database, the incoming CRO works with the Sponsor to determine a good data cut off point and to decide what data will need to be re-entered and whether to re-use the edit checks and case report forms (CRF) from the existing database to maintain the same look and feel of data entry. During the process of building a new database, data issues may be discovered in the existing database. Therefore, it is important to determine how data discrepancies will be handled and to add this process to the data management plan.  

    If an analysis is going to be performed, the Sponsor will need to work with a biostatistics vendor to combine the datasets from both databases. Further, the Sponsor will need to determine whether the outgoing CRO will be responsible for all archival activities related to their study participation to ensure that all documentation from the existing database is provided in the Trial Master File (TMF). Whichever database transfer option the Sponsor selects, the timeline and steps required for the transfer should be defined in the transition plan.

    The most common and preferred option among Sponsors for transferring a study database is a direct transfer of the database URL or the study database and all environments and modules, along with administrative access, to the incoming CRO.

    Performing a Gap Analysis and Quality Review

    Once a database transfer option has been chosen, the next step is to identify any issues related to the database using the documents provided by the Sponsor or outgoing CRO. Any issues discovered are documented in a findings log.  

    The Lead Data Manager begins the gap analysis by cross-checking the CRFs to the protocol to ensure all assessment data are collected. This is followed by review of the edit check specifications to ensure that they are sufficient for catching site data entry issues. 

    Then, the back-end configuration settings of the outgoing and incoming CRO are compared. The Sponsor, Lead Data Manager, and Database Programmer should meet to discuss any findings, questions, concerns, or suggestions for changes. If any changes are to be implemented, it is important for all stakeholders to understand any downstream effects resulting from these changes. It is important to remember for some EDC systems, the configuration settings and setup at the outgoing CRO may be at a high level and changes to these settings may not be possible as they may affect all EDC databases across different Sponsors. 

    Other important items to complete during this phase of database transition include: 

    • Determining whether any protected health information (PHI) has been collected. If so, CRF changes will be required to remove PHI to protect patient privacy. 
    • Identifying any blinded forms that are restricted to certain roles. If such forms exist, test that only those roles can view the data. 
    • Confirming that all modules linked to the database, such as randomization or drug dispensation, are working as expected 
    • Confirming the coding dictionaries are the expected version and finding out whether they need to be updated 
    • Checking that all roles and trainings map correctly 
    • Reviewing email notifications, removing or adding individuals, and testing those notifications 
    • Entering a clean test patient to identify queries that misfire or determine whether new edit check specifications should be added 
    Once a database transfer option has been chosen, the next step is to identify and document any issues related to the database using a gap analysis and cross-checking the CRFs to the protocol.

    Modifying and Validating the Database

    Discoveries made during the gap analysis and quality review often lead to potential database modifications. Once these updates are approved by the Sponsor and programmed by the Database Programming team, it is necessary to perform internal user acceptance testing (UAT) to ensure the database works as expected. This may be followed by Sponsor UAT. 

    Prior to re-opening the database, the incoming CRO performs a thorough review of the user access listing in collaboration with the Sponsor. When the Sponsor gives their approval, the new database is ready to go live. 

    Key Takeaway

    Effective, efficient migration of study data from one database to another requires clear communication and close collaboration between the Sponsor and the incoming CRO. Meticulous planning and detailed execution minimize the risks of database transfer and set up the rescue study for success.

    To learn more about how Precision for Medicine can help you transition a study, click here.  


    • Nancy Bates

      Nancy Bates is an Associate Director of Data Management at Precision for Medicine with over 20 years of data management experience, having worked in both the CRO and pharmaceutical space. She has successfully managed Data Management projects for many programs and excels at process analysis and process improvements. As a leader, she is a champion for her team members, helping to train and support them as they progress in their careers.

    Related Posts

    Case Study: An Advanced Approach to Integrated Summary of Safety Studies 

    Veronica Ruvolo

    Sep 29, '23 · 3 min. read

    Pros and Cons: Innovative Study Designs vs. Traditional FIH

    Rosa Canals López

    Apr 17, '23 · 2 min. read

    Overview: Innovative Study Designs vs. Traditional FIH

    Rosa Canals López

    Apr 17, '23 · 4 min. read

    Phase I Clinical Trial Designs: Modified Toxicity Probability Interval (mTPI-2)

    Fred Snikeris, PhD

    Mar 28, '23 · 2 min. read

    Precision for Medicine is part of the Precision Medicine Group, an integrated team of experts that extends Precision for Medicine’s therapeutic development capabilities beyond approval and into launch strategies, marketing communication, and payer insights. As one company, the Precision Medicine Group helps pharmaceutical and life-sciences clients conquer product development and commercialization challenges in a rapidly evolving environment.

    Visit the website
    Clinical Trial Services
    • Overview
    • Global Clinical Trial Support
    • Clinical Trial Management
    • Clinical Development Strategy
    • Clinical Trial Design
    • Biostatistics
    • Clinical Sample Management
    • Clinical Research Organization
    Specialty Lab Services
    • Overview
    • Immune Monitoring
    • Flow Cytometry
    • Genomics
    • Tissue & Liquid Biopsy
    • Bioanalytical Testing
    • Cytokine Analysis
    • Biospecimens
    • Sample Processing
    • Global Specimen Transport & Biostorage
    • Contract Research Organization
    • Bioanalysis
    • Neutralizing Antibody (NAb) Assays
    • PBMC Processing
    Data Sciences
    • Overview
    • Biostatistics
    • Clinical Data Management
    • Biometrics
    • QuartzBio
    • Virtual Sample Inventory Management
    Therapeutic Expertise
    • Overview
    • Preclinical Development
    • Early Phase Trials (I-IIa)
    • Late Phase Trials (IIb-III)
    • Oncology and Immuno-Oncology
    • Rare & Orphan Disease
    • Cell & Gene Therapy
    • Neurology
    • COVID-19
    • Autoimmune & Allergy
    • Pediatric
    • Companion Diagnostics
    About Us
    • Our Passion
    • Meet Our People
    • Careers
    • ESG Policy
    • Regulatory Information

    News & Insights
    • Publications
    • Case Studies
    • Thought Leadership
    • News
    • Events
    © 2023 Precision Medicine Group, LLC. All rights reserved. Privacy Policy    GDPR